Literature DB >> 9462368

Cardiorespiratory and vascular dysfunction related to major reconstructive orthopedic surgery.

O E Dahl1.   

Abstract

Major orthopedic reconstructive surgery is highly traumatic and may be associated with serious peri-operative cardiorespiratory and vascular complications which occasionally may be fatal. These complications are commonest in patients receiving cemented hip prostheses following femoral neck fractures. The etiology is multifactorial. Bone traumatization induces activation of the hemostatic system, i.e., thrombin generation, in venous blood draining the operation area. When this activated blood passes the lung, more thrombin is generated and the blood becomes hypercoagulable and causes fibrin-formation in the lung vessels, with trapping of cellular debris. Thrombin has many hormone-like effects beyond its function in the coagulation cascade system. It may increase vein wall permeability and cause constriction of vessels, which increases blood pressure in the lung. In addition, impaction of bone cement to fill bone cavities or to fix prostheses causes additional mechanical trauma and further release of procoagulant substances into venous blood. Further, release of the cytotoxic chemical methyl-methacrylate monomer into venous blood is superimposed on the thrombin-primed hemostatic disturbances in the lung microvasculature. All these effects may finally induce hemodynamic insufficiency, which occasionally may be fatal. To prevent these adverse reactions, thrombin activity should be reduced and impaction of bone cement minimized.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462368     DOI: 10.3109/17453679708999038

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  8 in total

Review 1.  Orthopaedic surgery as a model for drug development in thrombosis.

Authors:  Ola E Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Authors:  Bengt I Eriksson; Ola E Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Perioperative mortality in hip fracture patients treated with cemented and uncemented hemiprosthesis: a register study of 11,210 patients.

Authors:  Ove Talsnes; Tarjei Vinje; Jan Erik Gjertsen; Ola E Dahl; Lars B Engesæter; Valborg Baste; Are Hugo Pripp; Olav Reikerås
Journal:  Int Orthop       Date:  2013-03-19       Impact factor: 3.075

4.  Osteoblast response to polymethyl methacrylate bioactive glass composite.

Authors:  M Hautamäki; V V Meretoja; R H Mattila; A J Aho; P K Vallittu
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

5.  Letter to the Editor: Cemented or Uncemented Hemiarthroplasty for Femoral Neck Fracture? Data from the Norwegian Hip Fracture Register.

Authors:  Ola E Dahl; Are Hugo Pripp
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

6.  Postoperative respiratory failure necessitating transfer to the intensive care unit in orthopedic surgery patients: risk factors, costs, and outcomes.

Authors:  Roman Melamed; Lori L Boland; James P Normington; Rebecca M Prenevost; Lindsay Y Hur; Leslie F Maynard; Molly A McNaughton; Tyler G Kinzy; Adnan Masood; Mehdi Dastrange; Joseph A Huguelet
Journal:  Perioper Med (Lond)       Date:  2016-08-02

Review 7.  Long-term effects of cemented and cementless fixations of total knee arthroplasty: a meta-analysis and systematic review of randomized controlled trials.

Authors:  Cheng Chen; Yanyan Shi; Zhanpo Wu; Zengxin Gao; Youmin Chen; Changzheng Guo; Xianguo Bao
Journal:  J Orthop Surg Res       Date:  2021-10-12       Impact factor: 2.359

8.  The proportion of perioperative mortalities attributed to cemented implantation in hip fracture patients treated by hemiarthroplasty.

Authors:  Are Hugo Pripp; Ove Talsnes; Olav Reikerås; Lars B Engesæter; Ola E Dahl
Journal:  Hip Int       Date:  2014-02-11       Impact factor: 2.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.